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Background: There is no prospective randomized data comparing laparoscopic to open hepatectomy.
This study compared short- and long-term outcomes in patients undergoing hepatectomy for colorectal
metastases (CRM), who were suitable for either laparoscopic or open surgery.
Methods: Data were prospectively collected from consecutive patients undergoing hepatic resection of
CRM at a single centre (1987–2007). Patients who were suitable for laparoscopic resection (Group 1) were
compared with patients whose tumour characteristics would best be considered for open resection
(Group 2).
Results: Out of 1152 hepatectomies, 266 (23.1%) were deemed suitable for a laparoscopic approach.
The median (IQR) number of metastases was greater in Group 2 [2(1–20) vs. 1(1–10), P < 0.001], as was
the mean (SD) tumour size [5.3(3.6) cm vs. 3.3(1.2) cm, P < 0.001]. The median (IQR) operation time [210
(70) min vs. 240 (90) min, P < 0.001] and blood loss [270 (265) ml vs. 355 (320) ml, P < 0.001] were less
in Group 1. There was no difference in length of stay, morbidity or mortality. Patients in Group 2 had a
higher R1 resection rate (14.9%) compared with Group 1 (4.5%, P < 0.001) and lower 5-year survival
(37.8% vs. 44.2%, P = 0.005).
Discussion: Current criteria for laparoscopic hepatectomy selects patients who have more straight-
forward surgery, with less risk of an involved resection margin and better long-term survival, compared
with patients unsuited to a laparoscopic approach. Clearly defined criteria for laparoscopic hepatectomy
are essential to allow meaningful analysis of outcomes and the results of unrandomized series of
laparoscopic hepatectomies must be interpreted with caution.
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Introduction
Liver resection, in combination with neoadjuvant or adjuvant
chemotherapy, is firmly established as the standard of care for
patients with colorectal metastases, with variable 5-year survival
rates ranging from 25 to 44%.1–5 Advances in anaesthetic and
surgical techniques have improved the short-term outcomes
from open liver resection, with in-hospital mortality less than
4% in modern case series.3,5 Liver resection has associated peri-
operative morbidity, including wound complications, hepatic
insufficiency, bile leak, bleeding, renal failure and cardio-
respiratory compromise and complications can occur in up to
30% of cases.5,6
These data were presented in part by the corresponding author, at the Inter-
national Consensus Conference on Laparoscopic Liver Surgery, Louisville,
Kentucky, USA, November 2008.
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Minimally invasive surgery has claimed its rite of passage in
many intra-abdominal procedures, with laparoscopic cholecystec-
tomy, fundoplication, splenectomy and colonic resection the pre-
ferred standard of care. However, the place for laparoscopic liver
surgery remains controversial. The first anatomical laparoscopic
liver resection was a left lateral sectionectomy, reported in 1996 by
Azagra.7 With advances in equipment and techniques, hepatic
surgeons are rising to the challenge of laparoscopic hepatectomy.
As with laparoscopic colorectal surgery and laparoscopic chole-
cystectomy, there are potential short-term advantages to laparo-
scopic hepatectomy in terms of reduced post-operative wound
complications and pain, better cosmesis, shorter in-hospital stay
and early return to work.8,9 However, any laparoscopic operation
must have an equivalent morbidity and mortality to the open
approach before it is accepted as a viable alternative. Furthermore,
if the resection is for malignancy, oncological clearance and long-
term survival must be comparable to the open approach.
While there is no published randomized controlled trial of
laparoscopic vs. open hepatectomy, recent small case-controlled
studies suggest that a laparoscopic approach has superior short-
term outcomes to the open approach.10–15 These findings are con-
firmed in a meta-analysis,9 which concluded that laparoscopic
liver resection was safe and feasible when performed by experi-
enced surgeons in selected patients. However, it did acknowledge
a significant bias towards the laparoscopic approach in the
included studies. Thus these results must be interpreted with
caution. While the criteria for laparoscopic resection will vary
depending on the institution and surgeon’s experience, patient
comorbidity, previous surgery and preference, tumour size and
location are the major influences on the practicality of a laparo-
scopic operation. Cases suitable for a laparoscopic resection have
tended to be those with smaller metastases,16 more favourably
situated within the liver, not involving the hepatic veins/ caval
confluence or hilum.17,18 There is consensus that patients with
metastases of diameter greater than 6 cm, or metastases sited near
the hilum or vena cava, in segments 1, 4a, 7 and 8, or those
invading adjacent extra-hepatic structures, are more suitable for
open surgery.19,20
The aim of the present study was to compare short- and long-
term outcomes in patients undergoing liver resection for colorec-
tal metastases who were potentially suitable for a laparoscopic
hepatectomy, compared with those for whom an open resection
would be more appropriate. Specifically, we analysed the out-
comes of a large cohort of patients who underwent open liver
resection for colorectal metastases and compared a subset of that
group who were potentially suitable for a laparoscopic approach,
to those patients in whom resection was deemed unsuitable for
a minimal invasive approach by current criteria.
Patients and methods
Study subjects
This was a study of consecutive patients undergoing open hepatic
resection for colorectal liver metastases at a single tertiary referral
centre between 1987 and 2007, prior to the introduction of lap-
aroscopic liver resection in this unit. Patient inclusion criteria
were age older than 18 years and a confirmed primary colorectal
cancer with at least one resectable hepatic colorectal metastasis.
Patients with and without neoadjuvant chemotherapy prior to
liver resection were included in the study. Patients with extra-
hepatic disease or who were undergoing a repeat hepatic resection
were excluded from the analysis.
Data collection
Patient data were collected prospectively on a database (Access®;
Microsoft Corporation, Redmond,Washington, USA) comprising
268 data fields. This was compiled contemporaneously using
standardized proformas and encompassed patient symptoms, pre-
operative assessment, surgical treatment, post-operative course,
histopathology and long-term outcomes.
Data definitions
Resectable disease was defined as the ability to completely remove
all liver metastases, regardless of size, number, distribution or
width of resection margin, while preserving a sufficient volume of
functioning hepatic parenchyma [usually 25–30% of functioning
liver volume as estimated by computed tomography (CT) or
magnetic resonance imaging (MRI)], taking into account the
portal venous and hepatic arterial inflow, hepatic venous outflow
and biliary drainage. These criteria have remained unchanged
throughout the study period. The surgical and anaesthetic
techniques used have been previously reported by this unit.2,21,22
Peri-operative mortality was defined as a death during the same
hospital admission or within 90 days of the date of the operation.
Post-operative complications were classified as minor, relevant
(delayed patient discharge) or major (complications requiring
urgent medical or surgical intervention).
The nomenclature and extent of hepatic resection were
recorded according to the Brisbane 2000 Terminology of Liver
Anatomy and Resections.23 Major liver resection was defined as
the resection of three or more hepatic segments (hemihepatec-
tomy and extended hemihepatectomy). A minor resection was
defined as the resection of fewer than three segments, including
wedge resections.
Study design
All patients included in the study were divided into two groups
according to their suitability for laparoscopic (Group 1) or open
(Group 2) hepatectomy. Patients potentially suitable for a laparo-
scopic hepatectomy were those with metastases less than 6 cm in
maximum diameter, located in segments 2, 3, 4b, 5, 6, 7 or 8, who
underwent an anatomical or non-anatomical resection of disease.
Patients suitable for isolated resection of segments 4a, 7 or 8 were
excluded from Group 1. In addition, patients whose metastases
were 6 cm or greater in diameter, or close/involving the hepatic
venous/caval confluence, the hilum, or in the caudate (segment 1)
were deemed unsuitable for a potentially laparoscopic resection
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(Group 2). Similarly, patients who had bilobar disease, requiring
an extended resection, or major plus minor resection(s) were
excluded from the potentially laparoscopic group and entered into
Group 2. Finally, patients who had tumours invading adjacent
structures such as the diaphragm or chest wall and patients requir-
ing additional procedures not felt to be suitable for a minimally
invasive approach were excluded from Group 1. All patients who
underwent synchronous bowel and liver resection were deemed
suitable for a minimally invasive combined approach (Group 1).
These criteria were derived from literature review16–20 and the
consensus of expert opinion [Professor O James Garden, Profes-
sor Robert Padbury, Mr Nick O’Rourke and the senior author, Mr
Myrddin (Merv) Rees]. The authors accept that this retrospective
creation of two groups from a database is somewhat artificial and
does not necessarily reflect the current reality of selection for a
laparoscopic approach by increasingly experienced teams.
Study end-points
The short-term outcome measures included intra-operative
parameters such as operation time (taken from induction of ana-
esthesia to the patient leaving the operating room at the end of
surgery), intra-operative blood loss, the requirement for blood
transfusion and post-operative morbidity and mortality, in-
cluding the percentage of patients with involved (R1) resection
margins on histological analysis. The long-term outcome mea-
sured was cancer-specific survival. Follow-up of patients was per-
formed either in Basingstoke, or for patients residing at a distance
from the hospital by the local referring clinician (surgeon or
oncologist) in postal or telephone correspondence. There was a
dedicated data collator responsible for completion of the entire
follow-up data set.
Statistical analysis
Data were entered on a Statistical Package for the Social Sciences
(version 14) software package (SPSS Inc., Chicago, IL, USA). Data
were analysed using t-tests, chi-squared and Fisher’s exact test and
Kaplan–Meier survival curves, where appropriate. A P-value of
less than 0.05 was considered to indicate a statistically significant
difference between groups.
Results
Patient and primary tumour details
Figure 1 shows that 1152 liver resections were performed for col-
orectal metastases during the study period. Based on the type of
liver resection, there were 576 (50%) patients that were deemed
suitable for a minimally invasive approach. By excluding patients
with tumours 6 cm or greater in diameter, 370 patients remained.
Using stepwise exclusion for tumours close to or involving the
hilum or inferior vena cava (IVC), involvement of surrounding
structures and additional procedures not suitable for a laparo-
scopic approach, respectively, we identified 266 (23.1%) patients
as potentially suitable for a laparoscopic hepatectomy (Group 1).
The 886 excluded patients comprised Group 2. The patient demo-
graphics in Groups 1 and 2 are detailed in Table 1 and shows that
there was no difference between age, gender, Duke’s stage or
tumour differentiation between the groups. However, patients in
Group 2 were more likely to have an elevated carcinoembryonic
antigen (CEA) prior to their liver resection.
Details of hepatic metastases
Table 1 shows that the median (interquartile range) number of
liver metastases was 2 (1–20) in the patients unsuitable for a
laparoscopic resection, significantly higher than in those poten-
tially suitable for a laparoscopic approach [1(1–10), P < 0.001].
1152 liver resections for 
colorectal metastases 
(1987-2007) 
n = 297 
n = 278 
Group 2 
n = 886
Excluding metastases near 
or involving hilum/IVC 
(n=73)
Excluding metastases involving 
surrounding tissues 
(n=19)
Excluding patients who had additional procedure 
unsuitable for a laparoscopic approach (n=12) 
Excluding 576 
resections unsuitable 
for laparoscopic 
approach 
576 resections 
potentially suitable for 
laparoscopic approach 
Excluding metastases 
> 6cm in diameter 
(n=206)
n = 370 
Group 1 
n = 266
Figure 1 Flow chart to show derivation of study groups
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Furthermore, the metastases in the patients in this group (Group
2) were of larger maximum diameter (5.3 cm vs. 3.3 cm in Group
1, P < 0.001) and were more likely to involve both sides of the liver
(35.5%), compared with Group 1 (2.6%, P < 0.001) (Table 1).
Immediate intra-operative outcomes
The liver resections were significantly quicker, with less associated
blood loss in the patients potentially suited for a laparoscopic
approach (Group 1) (Table 2). The median blood loss in this
group was 270 ml, significantly lower than that in Group 2
(355 ml, P < 0.001). In Groups 1 and 2, the median fall in haemo-
globin was 1.3 and 1.4 g/dl, respectively, confirming no occult
haemorrhage in either group. There was no difference in the
number of intra-operative adverse surgical events between the
two groups (Table 2).
Short-term post-operative outcomes
The short-term outcomes are detailed in Table 2. The mean length
of stay was 10 days in both groups. There was no difference in
Table 1 Patient demographic characteristics and operative details
of patients undergoing hepatic resections for colorectal liver
metastases with a curative intent. Patients are grouped according to
whether they are considered suitable (Group 1) or not suitable
(Group 2) for laparoscopic resection
Risk factors Group 1
n = 266
Group 2
n = 886
P-value
Age mean (SD) 61.9 (10.4) 62.3 (10.1) 0.622
Gender 0.390
Female 105 (39.5) 324 (36.6)
Male 161 (60.5) 562 (63.4)
Primary tumour LN status 0.359
Negative 107 (40.4) 326 (37.2)
Positive 158 (59.6) 549 (62.7)
Primary tumour differentiation 0.237
Well 33 (12.5) 101 (11.5)
Moderate 205 (77.4) 713 (81.3)
Poor 27 (10.2) 63 (7.2)
Primary tumour type 0.745
Adenocarcinoma 259 (97.7) 854 (97.4)
Mucinous (>50%) 6 (2.3) 23 (2.6)
Neo-adjuvant chemotherapy 0.97
No 201 (75.6) 667 (75.5)
Yes 65 (24.4) 217 (24.5)
CEA level <0.001
<6 ng/ml 95 (35.7) 255 (28.8)
6–60 ng/ml 72 (27.1) 249 (28.1)
>60 ng/ml 22 (8.3) 182 (20.5)
Not measured 77 (28.9) 200 (22.6)
Number of hepatic metastases
Median (range) 1 (1–10) 2 (1–20) <0.001
1–3 251 (94.4) 715 (80.7)
>3 15 (5.6) 171 (19.3) <0.001
Distribution of liver metastases
Right lobe 201 (75.6) 407 (45.9)
Left lobe 56 (21.8) 149 (16.8)
Bilobar 7 (2.6) 315 (35.6) <0.001
Hilar / caudate / gall-bladder 0 (0) 294 (33.2) –
Local involvement
No infiltration 75 (9.0) 836 (91.8)
Diaphragmatic involvement 3 (5.0) 60 (6.6) 0.299
Other organs 2 (13.3) 15 (1.6) 0.563
Tumour diameter; mean (SD) 3.3 (1.2) 5.3 (3.6) <0.001
Type of liver resection
Right hepatectomy 137 (51.5) 178 (20.1)
Right hepatectomy + NA 0 77 (8.7)
Left hepatectomy 28 (10.5) 69 (7.8)
Left hepatectomy + NA 0 69 (7.8)
Extended right hepatectomy 0 130 (14.7)
Extended left hepatectomy 0 30 (3.4)
Left lateral sectionectomy 20 (7.5) 48 (5.4)
Left lateral sectionectomy + NA 1 (0.4) 42 (4.7)
Bisegmentectomy  NA 21 (7.9) 123 (13.9)
Segmentectomy  NA 39 (14.7) 85 (9.6)
NA (single or multiple) 20 (7.5) 35 (3.9)
Numbers in parentheses represent percentages unless otherwise stated.
CEA, carcinoembryonic antigen; NA, non-anatomical wedge excision.
Table 2 Intra-operative, post-operative outcomes and long-term
survival of patients undergoing hepatic resections for colorectal liver
metastases with a curative intent. Patients are grouped according
to whether they are considered suitable (Group 1) or not suitable
(Group 2) for laparoscopic resection
Risk factors Group 1
n = 266
Group 2
n = 886
P-value
Operative time; median (IQR) in min 210 (70) 240 (90) <0.001
Blood loss; median (IQR) in ml 270 (265) 355 (320) <0.001
Change in Hb; mean (SD) in units 1.3 (1.2) 1.4 (1.3) 0.395
Length of hospital stay: mean (SD) 10.0 (6.5) 10.5 (8.4) 0.338
Intra-operative adverse events 3 (1.1) 19 (2.1) 0.288
Post-operative adverse events
All complications 56 (21.1) 227 (25.6) 0.144
Slight 30 (11.3) 80 (9.0)
Relevant 18 (6.8) 108 (12.2)
Life threatening 8 (3.0) 39 (4.4) 0.044
Surgical complications 5 (1.9) 31 (3.5) 0.183
Medical complications 53 (19.9) 208 (23.5) 0.225
Post-operative mortality
30-day 3 (1.1) 12 (1.4) 0.533
90-day 4 (1.5) 15 (1.7) 0.544
Resection margin
Not involved (R0) 252 (95.5) 751 (85.1)
Involved (R1) 12 (4.5) 131 (14.9) <0.001
Cancer specific survival; in years
5-year (SE) 44.2 (3.8) 37.8 (2.1) 0.005a
7-year (SE) 36.9 (3.9) 32.1 (2.2) 0.004a
Median (SE) 4.5 (0.3) 3.5 (1.6) 0.005a
aLog-rank test.
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overall morbidity between the groups (24.8% vs. 25.6% P = NS),
but significantly more relevant and life-threatening complications
in the patients unsuited to a laparoscopic approach (P = 0.044).
The 30- and 90-day mortality were similar in Group 1 (1.1% and
1.5%) compared with Group 2 (1.4% and 1.7%, P = 0.53 and 0.54,
respectively). From the histological analysis, there were signifi-
cantly more patients with an involved (R1) resection margin in
Group 2 (14.9%) compared with Group 1 (4.5%, P < 0.001)
(Table 2).
Cancer-specific survival
The associated cancer-specific 5 and 7-year survival and median
cancer-specific survival for both groups is shown in Table 2. The 3,
5 and 7-year cancer-specific survival for patients in Group 1 was
69.7%, 44.2% and 36.9%, respectively, significantly better than
those patients in Group 2 (59.1%, 37.8% and 32.1%, P = 0.005,
0.005 and 0.004, respectively). Figure 2 shows a Kaplan–Meier
plot of the cancer-specific survival in both groups, with the
median survival being 4.5 years in Group 1, compared with
3.5 years in Group 2 (Log-rank test, chi-square = 7.873, 1 d.f.,
P = 0.005).
Discussion
The role of laparoscopic hepatectomy in the treatment of colorec-
tal metastases has yet to be defined. In a recent large case series
of 590 minimally invasive hepatic procedures, only 40 were for
colorectal liver metastases, the majority being for hepatocellular
carcinoma (n = 210) or benign tumours (n = 176).24 In the
Brisbane series of 84 laparoscopic hepatectomies, 33 (39%) were
for malignancy, with 22 being performed for colorectal
metastases.25 Whilst there is currently no prospective randomized
controlled trial of laparoscopic vs. open hepatectomy, some recent
case-controlled studies have attempted to compare the two
approaches.10–15
However, laparoscopic hepatectomy is still evolving and many
surgeons remain on a learning curve for this operation. Daniel
Cherqui recently published his experience of 166 laparoscopic
hepatectomies, performed between 1996 and 2007. He had a sig-
nificantly lower blood loss and conversion rate in the second half
of his series.26 As with any procedure, case selection is the key and
in the absence of randomized trials, this current study asks
whether the results of hepatectomy potentially suitable for a lap-
aroscopic approach are comparable to those where an open hepa-
tectomy would be more appropriate. From a large prospective
cohort of open liver resections performed in a single centre, those
cases potentially suitable for a laparoscopic approach were iden-
tified and their short-and long-term outcomes compared with
those cases where a laparoscopic approach was not feasible. Cases
suitable for a laparoscopic approach were by definition those with
smaller tumours, more favourably sited within the liver. In addi-
tion, this current study showed that these patients potentially
suited for a laparoscopic approach had fewer liver metastases,
with a lower pre-operative CEA, suggesting a lower tumour
burden compared with the potentially open group. While there
was no difference in Duke’s stage between the groups, patients
unsuitable for a laparoscopic approach (Group 2) were more
likely to have had bilobar disease. However, there was a similar
percentage of major resections in both groups (Table 1) and
indeed 62% of patients in the potentially laparoscopic group
underwent a major resection, which is in contrast to most pub-
lished series of laparoscopic liver resections. The study showed
that surgery took significantly longer in Group 2, with more
blood loss, although the median blood transfusion in both groups
was zero. This is likely to be related to the greater burden of
metastatic disease in this group and the more unfavourable
tumour location. Furthermore, in patients with a complex distri-
bution of liver metastases, who may have received neoadjuvant
chemotherapy, a parenchymal-sparing approach to liver resection
should be adopted, to avoid post-operative hepatic insufficiency.27
This is more challenging laparoscopically. A number of authors
have tried to address this potential bias regarding case selection
with case-controlled studies, and have shown reduced blood loss
in patients undergoing laparoscopic liver resection, compared
with open.10–15 These data support the findings of this current
study and thereby confirm that case-mix bias must be taken into
consideration when comparing the results of laparoscopic and
open liver resections.
This study found no difference in the length of hospital stay
between the two groups, with a mean stay of 10 days in each.
Group I,  n = 266      240          182           132            91            60
Group II, n = 886      709          514           320           207          143 
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Figure 2 Cancer-specific survival in patients undergoing hepatic
resection for colorectal liver metastases with a curative intent
grouped according to whether these are considered suitable (Group
1) or not suitable (Group 2) for laparoscopic resection. Log-rank:
chi-square = 7.873, 1 d.f., P = 0.005
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This is in the absence of an enhanced recovery programme, with
some patients living at a considerable distance (200 miles) from
the hospital. The median stay for all patients undergoing liver
resection in our centre in the past year (n = 175) is six days
(unpublished data) and with the adoption of an enhanced-
recovery programme, we are aiming to discharge most patients
in 3–4 days after a major hepatectomy. In Daniel Cherqui’s series
of 37 laparoscopic left lateral sectionectomies, performed
between 1997 and 2005, the mean length of stay was 7.8 days,28
although this was reduced to 4.3 days in the second half of his
series. In a Norwegian series of 53 laparoscopic hepatic resec-
tions, 42 of which were for colorectal metastases, the median
hospital stay was 3.5 days.29 In a case-controlled study of 20 cases
of laparoscopic liver resection compared with 20 open liver
resections, Troisi and co-workers showed that the laparoscopic
group had a shorter mean hospital stay (7.1 days) compared
with the open group (10.45 days, P = 0.008).30 However, in this
series, there was a 10% conversion rate to open for uncontrol-
lable haemorrhage, with one patient requiring haemodialysis.
Moreover, there was a 25% incidence of incisional hernias
recorded in the open group, which is extremely high and com-
pares unfavourably to that in our own experience, where it is
extremely rare. In this cohort, only two patients (0.17%) have
undergone a surgical repair of an incisional hernia, both at the
time of a repeat liver resection. The suggestion that a laparo-
scopic approach is associated with a shorter length of stay is sup-
ported by three further small case-controlled studies, which
show a reduction in hospital stay of 1,10 212 and 311 days, respec-
tively, using a laparoscopic approach.
Our study showed no difference in overall morbidity or mor-
tality between patients potentially suitable for a laparoscopic
approach, compared with those best suited for an open approach.
This finding is confirmed by two published meta-analyses on
laparoscopic vs. open liver resection8,9 and likely to be a testament
to improved peri-operative care worldwide. The involved (R1)
resection margin rate, however, was significantly higher in the
group unsuited for a laparoscopic approach (14.9% vs. 4.5%, P <
0.001). This is likely to be related to case-selection, as our Unit has
previously shown that a non-anatomical or extended resection, >3
hepatic metastases involving >50% of the liver and bilobar disease
are all independent predictors of a positive resection margin.31
These predictive factors not only reflect tumour load, but also the
proximity of metastases to key portal or venous structures. The
relationship between narrow or involved margins and extensive
disease was first demonstrated by Elias in 199832 and subsequently
confirmed by Pawlik.33 Patients with more metastases, bilobar
disease or those requiring an extended resection are more likely to
have a narrow resection margin because of the complexity of
achieving a radical clearance32 and these patients are not suitable
for a laparoscopic approach by current criteria. In a case series of
53 laparoscopic liver resections, 42 of which were for colorectal
metastases, despite the high proportion of non-anatomic resec-
tions (n = 45), which DeMatteo has shown are associated with a
higher R1 margin rate,34 the R1 rate was only 6%,29 comparable to
the findings in Group 1 of this study.
The 5-year cancer-specific survival for patients potentially
suitable for a laparoscopic liver resection was 44.2%, significantly
better than those patients unsuitable (37.8%, P = 0.005). This is
likely to be explained by the greater tumour burden in this latter
group (increased tumour size/ number and higher pre-operative
CEA) and their higher involved resection margin rate, as these
factors are well-established predictors of a poor long-tem out-
come.3,5,6 There are two published studies to date that looked at
long-term survival from laparoscopic liver resection for colorectal
metastases. The Brisbane group reported a 75% 2-year survival,25
with Gayet’s group reporting a 3-year overall and disease-free
survival of 87% and 51%, respectively, in 41 patients undergoing
laparoscopic liver resection for colorectal metastases.35 These sur-
vival figures are comparable with the 3-year disease-free survival
of 69.7% reported here in Group 1. Thus, with the current paucity
of prospective randomized or case-matched data, the long-term
outcome of laparoscopic compared with open liver resection for
colorectal metastases is as yet unclear.
In conclusion, this study shows that in patients with colorectal
liver metastases, the current criteria for laparoscopic hepatectomy
has selected a group of patients who have more straight-forward
surgery, removing a lower tumour burden, with less risk of an
involved resection margin and better long-term survival, com-
pared with patients unsuited to a laparoscopic approach. Clearly
defined criteria for laparoscopic liver resection are important to
allow risk-stratified comparison of outcomes in patients under-
going liver resection for colorectal metastases.
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